logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Bronchospasm Exerciseinduced

    Medications for Bronchospasm Exerciseinduced

    FiltersReset Filters
    3 results

    • albuterol sulfate

      (Albuterol Sulfate)
      Sandoz Inc
      Usage: Albuterol Sulfate Inhalation Aerosol is indicated for treating or preventing bronchospasm in patients aged 4 years and older with reversible obstructive airway disease and for preventing exercise-induced bronchospasm.

    • albuterol sulfate

      (Albuterol Sulfate)
      Armstrong Pharmaceuticals, Inc.
      Usage: Albuterol Sulfate Inhalation Aerosol is indicated for treating or preventing bronchospasm in patients aged 4 and older with reversible obstructive airway disease, as well as for preventing exercise-induced bronchospasm in the same age group.

    • montelukast sodium

      (MONTELUKAST SODIUM)
      Chartwell RX, LLC
      Usage: Montelukast sodium is indicated for the prophylaxis and chronic treatment of asthma in patients aged 12 months and older, prevention of exercise-induced bronchoconstriction in those 6 years and older, and relief of seasonal and perennial allergic rhinitis in patients 6 months and older. It is not for acute asthma attacks.